Top

World Journal of Urology

Published in:

01-09-2016 | Original Article

Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study

Authors: Mao Qiang Wang, Yan Wang, Jie Yu Yan, Kai Yuan, Guo Dong Zhang, Feng Duan, Kai Li

Published in: World Journal of Urology | Issue 9/2016

Abstract

Purpose

To compare the safety and efficacy of PAE for the treatment of benign prostatic hyperplasia (BPH) in men ≥75 years, who we defined as elderly, to those <75 years.

Methods

A total of 157 patients diagnosed with lower urinary tract symptoms (LUTS) due to BPH underwent PAE. Group A (n = 52) included patients ≥75 years, and group B (n = 105) included patients <75 years. Follow-up was performed using the International Prostate Symptoms Score (IPSS), quality of life (QoL), peak urinary flow rate (Q _max), post-void residual volume (PVR), the International Index of Erectile Function short form (IIEF-5), prostatic-specific antigen (PSA), and prostate volume (PV), at 1, 3, 6, and every 6 months thereafter.

Results

More coexistent systemic diseases were identified in group A than in group B (P < 0.05). Technical success rate of PAE was 90.4 % in group A and 95.2 % in group B (P = 0.06). A total of 147 patients had completed the follow-up with a mean of 20 months. Compared with the baseline, there were significant improvements in IPSS, QoL, Q _max, PV, PVR, and PSA in both groups after PAE. There were no significant differences in the changes of IPSS, Q _max, PVR, PSA, and IIEF-5 between groups after PAE. No major complications were noted.

Conclusion

PAE could be used as an effective, safe, and well tolerable method in the treatment of elderly symptomatic BPH patients, similarly to younger patients, and it may play an important role in patients in whom medical therapy has failed, who are at high surgical and anesthetic risk or who refuse the standard surgical therapy.

Pisco J, Campos Pinheiro L, Bilhim T, Duarte M, Rio Tinto H, Fernandes L, Vaz Santos V, Oliveira AG (2013) Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results. Radiology 266(2):668–677CrossRefPubMed

Carnevale FC, da Motta-Leal-Filho JM, Antunes AA, Baroni RH, Marcelino AS, Cerri LM, Yoshinaga EM, Cerri GG, Srougi M (2013) Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia. J Vasc Interv Radiol 24(4):535–542CrossRefPubMed

Bagla S, Martin CP, van Breda A, Sheridan MJ, Sterling KM, Papadouris D, Rholl KS, Smirniotopoulos JB, van Breda A (2014) Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia. J Vasc Interv Radiol 25(1):47–52CrossRefPubMed

Gao YA, Huang Y, Zhang R, Yang YD, Zhang Q, Hou M, Wang Y (2014) Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate—a prospective, randomized, and controlled clinical trial. Radiology 270(3):920–928CrossRefPubMed

Abt D, Mordasini L, Hechelhammer L, Kessler TM, Schmid HP, Engeler DS (2014) Prostatic artery embolization versus conventional TUR-P in the treatment of benign prostatic hyperplasia: protocol for a prospective randomized non-inferiority trial. BMC Urol 14:94CrossRefPubMedPubMedCentral

Kurbatov D, Russo GI, Lepetukhin A, Dubsky S, Sitkin I, Morgia G, Rozhivanov R, Cimino S, Sansalone S (2014) Prostatic artery embolization for prostate volume greater than 80 cm³: results from a single-center prospective study. Urology 84(2):400–404CrossRefPubMed

Jones P, Rai BP, Nair R, Somani BK (2015) Current status of prostate artery embolization for lower urinary tract symptoms: review of world literature. Urology 86(4):676–681CrossRefPubMed

Russo GI, Kurbatov D, Sansalone S, Lepetukhin A, Dubsky S, Sitkin I, Salamone C, Fiorino L, Rozhivanov R, Cimino S, Morgia G (2015) Prostatic arterial embolization vs open prostatectomy: a 1-year matched-pair analysis of functional outcomes and morbidities. Urology 86(2):343–348CrossRefPubMed

Wang MQ, Guo LP, Zhang GD, Yuan K, Li K, Duan F, Yan JY, Wang Y, Kang HY, Wang ZJ (2015) Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population. BMC Urol 15:33CrossRefPubMedPubMedCentral

10.

Mitropoulos D, Artibani W, Graefen M, Remzi M, Rouprêt M, Truss M, European Association of Urology Guidelines Panel (2012) Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. Eur Urol 61(2):341–349CrossRefPubMed

11.

Carnevale FC, Antunes AA (2013) Prostatic artery embolization for enlarged prostates due to benign prostatic hyperplasia. How I do it. Cardiovasc Intervent Radiol 36(6):1452–1463CrossRefPubMed

12.

Bilhim T, Pisco J, Rio Tinto H, Fernandes L, Campos Pinheiro L, Duarte M, Pereira JA, Oliveira AG, O’Neill J (2013) Unilateral versus bilateral prostatic arterial embolization for lower urinary tract symptoms in patients with prostate enlargement. Cardiovasc Intervent Radiol 36(2):403–411CrossRefPubMed

13.

Pisco JM, Rio-Tinto H, Campos-Pinheiro L, Bilhim T (2013) Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol 23(9):2561–2572CrossRefPubMed

14.

McWilliams JP, Kuo MD, Rose SC, Bagla S, Caplin DM, Cohen EI, Faintuch S, Spies JB, Saad WE, Nikolic B, Society of Interventional Radiology (2014) Society of interventional radiology position statement: prostate artery embolization for treatment of benign disease of the prostate. J Vasc Interv Radiol 25(9):1349–1351CrossRefPubMed

15.

Grosso M, Balderi A, Arnò M, Sortino D, Antonietti A, Pedrazzini F, Giovinazzo G, Vinay C, Maugeri O, Ambruosi C, Arena G (2015) Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients. Radiol Med 120(4):361–368CrossRefPubMed

16.

Wang M, Guo L, Duan F, Yuan K, Zhang G, Li K, Yan J, Wang Y, Kang H, Wang Z (2015) Prostatic arterial embolization for the treatment of lower urinary tract symptoms as a result of large benign prostatic hyperplasia: a prospective single-center investigation. Int J Urol 22(8):766–772CrossRefPubMed

17.

Antunes AA, Carnevale FC, da Motta Leal Filho JM, Yoshinaga EM, Cerri LM, Baroni RH, Marcelino AS, Cerri GG, Srougi M (2013) Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study. Cardiovasc Intervent Radiol 36(4):978–986CrossRefPubMed

18.

Lebdai S, Delongchamps NB, Sapoval M, Robert G, Amouyal G, Thiounn N, Karsenty G, Ruffion A, de La Taille A, Descazeaud A, Mathieu R (2015) Early results and complications of prostatic arterial embolization for benign prostatic hyperplasia. World J Urol [Epub ahead of print, PMID: 26276151]. doi: 10.1007/s00345-015-1665-6

Title: Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study
Authors: Mao Qiang Wang
Yan Wang
Jie Yu Yan
Kai Yuan
Guo Dong Zhang
Feng Duan
Kai Li
Publication date: 01-09-2016
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 9/2016
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-016-1771-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2016

Clinical staging of ketamine-associated urinary dysfunction: a strategy for assessment and treatment

Hybrid laparoendoscopic single-site surgery of upper urinary tract with the use of mini-laparoscopic instruments: cosmetic outcome and midterm oncological outcome

Factors affecting post-pubertal penile size in patients with hypospadias

Clinical efficacy of combination therapy with an alpha blocker and low-dose sildenafil on post-therapy lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer

3D Navigo™ versus TRUS-guided prostate biopsy in prostate cancer detection

Single- versus dual-console robotic surgery: dual improves the educational experience for trainees